1. Optical coherence tomography to monitor vigabatrin toxicity in children
- Author
-
Janet L. Alexander, William McClintock, Mohamad S. Jaafar, Marlet Bazemore, Madison M. Berl, Marijean Miller, Heather de Beaufort, Nancy Elling, Catherine Origlieri, William Madigan, Jonathan Taylormoore, Kelly A. Hutcheson, Brooke Geddie, and Bethany Karwoski
- Subjects
Male ,Retinal Ganglion Cells ,medicine.medical_specialty ,Adolescent ,genetic structures ,Nerve fiber layer ,Retina ,Vigabatrin ,03 medical and health sciences ,chemistry.chemical_compound ,Nerve Fibers ,0302 clinical medicine ,Retinal Diseases ,Tuberous Sclerosis ,Ophthalmology ,Electroretinography ,Humans ,Medicine ,Prospective Studies ,Child ,Prospective cohort study ,medicine.diagnostic_test ,Cumulative dose ,business.industry ,Fundus photography ,Infant ,Retinal ,eye diseases ,Surgery ,medicine.anatomical_structure ,chemistry ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,030221 ophthalmology & optometry ,Anticonvulsants ,Female ,sense organs ,Visual Fields ,business ,Tomography, Optical Coherence ,030217 neurology & neurosurgery ,medicine.drug - Abstract
The antiepileptic drug vigabatrin is known to cause permanent loss of vision. Both visual field testing and electroretinogram are used to detect retinal damage. Adult data on optical coherence tomography (OCT) shows that retinal nerve fiber layer (RNFL) thinning may be an early indicator of vigabatrin-induced retinal toxicity. The purpose of this study was to investigate whether OCT can detect early vigabatrin-induced retinal toxicity in children.Pediatric patients (≤18 years of age) requiring vigabatrin for seizure control who were followed at our institution were invited to participate. Patients were examined according to manufacturer guidelines, with most examinations taking place under general anesthesia. RNFL thickness was measured by OCT (Stratus Model 3000, Zeiss) and compared to total cumulative dose of vigabatrin. In most cases, indirect ophthalmoscopy, fundus photography, and electroretinography were also performed.OCT and complete dosing data was available for 19 patients. Patients with tuberous sclerosis (TS, n = 12) received higher cumulative doses (mean, 1463 g) than non-TS patients (mean, 351 g, P = 0.044). RNFL thinning was detected in the nasal (P 0.01), superior (P 0.01), and inferior (P 0.05) quadrants in patients with TS, particularly once cumulative dose exceeded 1500 g.In our study population of patients with TS, higher cumulative doses of vigabatrin were associated with RNFL thinning in the nasal, superior, and inferior quadrants. These findings were pronounced once cumulative dose exceeded 1500 g. This pattern of RNFL thinning is similar to what has been shown in adult patients taking vigabatrin.
- Published
- 2016
- Full Text
- View/download PDF